Jon Mordal

482 total citations
22 papers, 352 citations indexed

About

Jon Mordal is a scholar working on Epidemiology, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jon Mordal has authored 22 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Psychiatry and Mental health and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jon Mordal's work include Schizophrenia research and treatment (9 papers), Substance Abuse Treatment and Outcomes (8 papers) and Opioid Use Disorder Treatment (6 papers). Jon Mordal is often cited by papers focused on Schizophrenia research and treatment (9 papers), Substance Abuse Treatment and Outcomes (8 papers) and Opioid Use Disorder Treatment (6 papers). Jon Mordal collaborates with scholars based in Norway, Denmark and Sweden. Jon Mordal's co-authors include Jørgen G. Bramness, Jørg Mørland, Björn Holm, Hallvard Gjerde, Asbjørg S. Christophersen, Eivind Andersen, Jens Egeland, John Abel Engh, Gunnar Morken and Egil W. Martinsen and has published in prestigious journals such as Schizophrenia Bulletin, Psychoneuroendocrinology and Psychiatry Research.

In The Last Decade

Jon Mordal

19 papers receiving 343 citations

Peers

Countries citing papers authored by Jon Mordal

Since Specialization

Citations

This map shows the geographic impact of Jon Mordal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Mordal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Mordal more than expected).

Fields of papers citing papers by Jon Mordal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Mordal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Mordal. The network helps show where Jon Mordal may publish in the future.

Co-authorship network of co-authors of Jon Mordal

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Mordal. A scholar is included among the top collaborators of Jon Mordal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Mordal. Jon Mordal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of dextroamphetamine substitution on the use of illicit amphetamines in adults with amphetamine dependence: a study protocol for the multicentre double blind randomised controlled trial ATLAS4Dependence 2025 ·BMJ Open ·Fatemeh Chalabianloo, Lars Thore Fadnes, Jon Mordal, Olav Spigset, Else‐Marie Løberg, Anne Halmøy, (unknown), Chad Andersen, (unknown), Jörg Aßmus, Aleksander H. Erga, Kristin Klemmetsby Solli, (unknown), Marco Bo Hansen, (unknown), Nadine Ezard, Nicholas Lintzeris, Kjell Arne Johansson	0
2	Changes in quality of life during 52 weeks of extended-release naltrexone treatment, subsequent by a 1-year post-treatment period 2025 ·Drug and Alcohol Dependence ·(unknown), Bente Weimand, Jūratė Šaltytė Benth, John‐Kåre Vederhus, Jon Mordal, (unknown), Lars Tanum, Kristin Klemmetsby Solli	0
3	Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study 2025 ·Journal of Pain Research ·(unknown), (unknown), Kristin Klemmetsby Solli, Bente Weimand, (unknown), Lars Tanum, Jon Mordal	0
4	High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study 2025 ·Addiction Science & Clinical Practice ·Jon Mordal, (unknown), (unknown), John‐Kåre Vederhus, Arild Opheim, (unknown), (unknown), Bente Weimand, Kristin Klemmetsby Solli, Lars Tanum	1
5	Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study 2024 ·European Addiction Research ·(unknown), (unknown), Jūratė Šaltytė Benth, Kristin Klemmetsby Solli, Jon Mordal, Else‐Marie Løberg, Bente Weimand, Lars Tanum	4
6	Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia—a randomized controlled trial 2023 ·Frontiers in Psychiatry ·(unknown), John Abel Engh, Eivind Andersen, (unknown), Jens Egeland, Ragnhild Sørum Falk, (unknown), Jon Mordal, Jimmi Nielsen, Thor Ueland, Torkel Vang, Mats Fredriksen	3
7	The relationship between the brain-derived neurotrophic factor and neurocognitive response to physical exercise in individuals with schizophrenia 2023 ·Psychoneuroendocrinology ·(unknown), Jens Egeland, Thor Ueland, Eivind Andersen, (unknown), (unknown), Jon Mordal, René Holst, John Abel Engh	2
8	High-intensity interval training may reduce depressive symptoms in individuals with schizophrenia, putatively through improved VO2max: A randomized controlled trial 2022 ·Frontiers in Psychiatry ·(unknown), John Abel Engh, René Holst, (unknown), (unknown), Eivind Andersen, Jon Mordal, Jens Egeland	13
9	Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms 2021 ·BMC Psychiatry ·(unknown), John Abel Engh, Jens Egeland, Eivind Andersen, Ole A. Andreassen, (unknown), Ragnhild Sørum Falk, (unknown), Morten Lindberg, Jon Mordal, Jimmi Nielsen, Nils Eiel Steen, Thor Ueland, Torkel Vang, Mats Fredriksen	6
10	High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial 2020 ·European Archives of Psychiatry and Clinical Neuroscience ·(unknown), Jens Egeland, (unknown), (unknown), Eivind Andersen, Jon Mordal, Pål Ulleberg, John Abel Engh	24
11	O4.3. SHARED AND DIFFERENTIAL NEUROCOGNITIVE EFFECTS COMPARING HIGH-INTENSITY INTERVAL TRAINING AND ACTIVE VIDEO-GAMING IN SCHIZOPHRENIA – RESULTS FROM AN RCT 2020 ·Schizophrenia Bulletin ·(unknown), Jens Egeland, (unknown), Eivind Andersen, Pål Ulleberg, (unknown), Jon Mordal, John Abel Engh	2
12	The Association Between Cardiorespiratory Fitness and Cognition Appears Neither Related to Current Physical Activity Nor Mediated by Brain-Derived Neurotrophic Factor in a Sample of Outpatients With Schizophrenia 2019 ·Frontiers in Psychiatry ·(unknown), Jens Egeland, Eivind Andersen, Jon Mordal, Ole A. Andreassen, Thor Ueland, (unknown), (unknown), John Abel Engh	5
13	Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial 2015 ·Trials ·John Abel Engh, Eivind Andersen, (unknown), Egil W. Martinsen, Jon Mordal, Gunnar Morken, Jens Egeland	26
14	Evaluation of the Alcohol Use Disorders Identification Test and the Drug Use Disorders Identification Test among Patients at a Norwegian Psychiatric Emergency Ward 2013 ·European Addiction Research ·(unknown), Jon Mordal, Anne H. Berman, Jørgen G. Bramness	14
15	Influence of Drugs of Abuse and Alcohol Upon Patients Admitted to Acute Psychiatric Wards 2013 ·Journal of Clinical Psychopharmacology ·Jon Mordal, (unknown), Björn Holm, Jørg Mørland, Jørgen G. Bramness	8
16	A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards 2012 ·Psychiatry Research ·(unknown), Jon Mordal, Björn Holm, Jørg Mørland, Jørgen G. Bramness	47
17	Psychoactive substance use among patients admitted to an acute psychiatric ward: Laboratory findings and associations with clinical characteristics 2010 ·Nordic Journal of Psychiatry ·Jon Mordal, Björn Holm, Michael Gossop, Maria Romøren, Jørg Mørland, Jørgen G. Bramness	11
18	Recent Substance Intake Among Patients Admitted to Acute Psychiatric Wards 2010 ·Journal of Clinical Psychopharmacology ·Jon Mordal, Björn Holm, Jørg Mørland, Jørgen G. Bramness	15
19	Comparison of Drug Concentrations in Blood and Oral Fluid Collected with the Intercept(R) Sampling Device 2010 ·Journal of Analytical Toxicology ·Hallvard Gjerde, Jon Mordal, Asbjørg S. Christophersen, Jørgen G. Bramness, Jørg Mørland	58
20	Norwegian version of the Mini-International Neuropsychiatric Interview: Feasibility, acceptability and test-retest reliability in an acute psychiatric ward 2009 ·European Psychiatry ·Jon Mordal, (unknown), Jørgen G. Bramness	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact